Category: Drug Packs

April 10, 2021 0

Benefits of ifosfamide continue to outweigh risks: EMA

By FM

The Pharmacovigilance Risk Assessment Committee (PRAC) of EMA has concluded that the benefits of ifosfamide solutions for infusion continue to outweigh their risks in the treatment of different types of cancers, including various solid tumours and blood cancers such as lymphomas.

March 6, 2021 0

D-2-HG INHIBITION SHOWS PROMISE IN ASTROCYTOMA

By FM

In a study funded by the National Institutes of Health (NIH), researchers tested a novel combination treatment approach on mice with tumours with characteristics similar to human astrocytomas — a type of slow-growing glioma—and found tumour regression in 60 percent of the mice treated.

February 6, 2021 0

A treasure trove of therapeutics?

By FM

Cyanobacteria are promising but still unexplored natural resources offering a wealth of chemicals for the discovery of pharmaceutical compounds and new drugs.

June 29, 2018 0

Large-sized generic names

By CH Unnikrishnan

The Union government has mooted a proposal to make it mandatory for all generic medicine manufacturers to print the generic names of drugs on the labels larger than the brand or trade names.